Abbott LaboratoriesABTNYSE
Loading
Dividends/Share Growth Recovery in ProgressRecovering
Percentile Rank28
3Y CAGR-7.1%
5Y CAGR-46.0%
Year-over-Year Change
Year-over-year dividends per share growth
3Y CAGR
-7.1%/yr
vs -40.4%/yr prior
5Y CAGR
-46.0%/yr
Recent acceleration
Acceleration
+33.3pp
Accelerating
Percentile
P28
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 0.02% |
| Q3 2025 | -0.29% |
| Q2 2025 | 0.68% |
| Q1 2025 | 6.15% |
| Q4 2024 | -0.05% |
| Q3 2024 | -0.13% |
| Q2 2024 | 0.42% |
| Q1 2024 | 7.77% |
| Q4 2023 | 0.27% |
| Q3 2023 | -0.13% |
| Q2 2023 | 0.08% |
| Q1 2023 | 7.90% |
| Q4 2022 | 0.02% |
| Q3 2022 | 0.14% |
| Q2 2022 | -0.50% |
| Q1 2022 | 5.04% |
| Q4 2021 | -0.14% |
| Q3 2021 | 0.01% |
| Q2 2021 | 0.60% |
| Q1 2021 | 24.41% |
| Q4 2020 | 0.38% |
| Q3 2020 | -0.57% |
| Q2 2020 | 0.53% |
| Q1 2020 | 11.92% |
| Q4 2019 | 0.16% |
| Q3 2019 | 0.12% |
| Q2 2019 | 0.35% |
| Q1 2019 | 13.59% |
| Q4 2018 | 0.24% |
| Q3 2018 | -0.11% |
| Q2 2018 | 0.55% |
| Q1 2018 | 5.24% |
| Q4 2017 | 0.04% |
| Q3 2017 | 0.03% |
| Q2 2017 | 0.31% |
| Q1 2017 | 1.15% |
| Q4 2016 | 0.48% |
| Q3 2016 | -0.16% |
| Q2 2016 | -0.32% |
| Q1 2016 | 7.20% |